Healthcare Value Capital as of Sept. 30, 2012
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 44 positions in its portfolio as reported in the September 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| St. Jude Medical | 8.8 | $11M | 262k | 42.13 | |
| Forest Laboratories | 7.9 | $9.8M | 276k | 35.61 | |
| Sanofi-Aventis SA (SNY) | 7.6 | $9.5M | 220k | 43.06 | |
| Omnicare | 5.8 | $7.3M | 215k | 33.97 | |
| Boston Scientific Corporation (BSX) | 3.2 | $4.0M | 689k | 5.74 | |
| Universal Health Services (UHS) | 3.1 | $3.9M | 86k | 45.72 | |
| Pfizer (PFE) | 3.1 | $3.8M | 154k | 24.85 | |
| AstraZeneca (AZN) | 3.1 | $3.8M | 80k | 47.86 | |
| NuVasive | 3.0 | $3.8M | 165k | 22.91 | |
| Abbott Laboratories (ABT) | 2.8 | $3.4M | 50k | 68.56 | |
| Allscripts Healthcare Solutions (MDRX) | 2.7 | $3.4M | 270k | 12.42 | |
| Gilead Sciences (GILD) | 2.7 | $3.3M | 50k | 66.34 | |
| AmerisourceBergen (COR) | 2.6 | $3.2M | 83k | 38.72 | |
| Cardinal Health (CAH) | 2.5 | $3.2M | 82k | 38.96 | |
| Teva Pharmaceutical Industries (TEVA) | 2.5 | $3.1M | 75k | 41.41 | |
| Obagi Medical Products | 2.5 | $3.1M | 249k | 12.41 | |
| Humana (HUM) | 2.4 | $3.0M | 43k | 70.14 | |
| Sigma-Aldrich Corporation | 2.3 | $2.9M | 40k | 71.98 | |
| Qlt | 2.2 | $2.7M | 350k | 7.79 | |
| Centene Corporation (CNC) | 2.1 | $2.6M | 70k | 37.40 | |
| Impax Laboratories | 2.1 | $2.6M | 100k | 25.96 | |
| Novo Nordisk A/S (NVO) | 2.0 | $2.5M | 16k | 157.81 | |
| CryoLife (AORT) | 2.0 | $2.5M | 375k | 6.72 | |
| Hca Holdings (HCA) | 2.0 | $2.5M | 75k | 33.25 | |
| Baxter International (BAX) | 1.9 | $2.4M | 40k | 60.28 | |
| Agilent Technologies Inc C ommon (A) | 1.9 | $2.3M | 60k | 38.45 | |
| Quest Diagnostics Incorporated (DGX) | 1.8 | $2.2M | 35k | 63.43 | |
| Pacira Pharmaceuticals (PCRX) | 1.7 | $2.1M | 119k | 17.40 | |
| Merck & Co (MRK) | 1.5 | $1.9M | 42k | 45.10 | |
| Edwards Lifesciences (EW) | 1.3 | $1.6M | 15k | 107.38 | |
| Valeant Pharmaceuticals Int | 1.1 | $1.4M | 25k | 55.28 | |
| ACCRETIVE Health | 1.0 | $1.3M | 113k | 11.16 | |
| Alkermes (ALKS) | 1.0 | $1.2M | 60k | 20.75 | |
| Life Technologies | 1.0 | $1.2M | 25k | 48.84 | |
| Jazz Pharmaceuticals (JAZZ) | 0.9 | $1.1M | 20k | 57.00 | |
| Nu Skin Enterprises (NUS) | 0.8 | $971k | 25k | 38.84 | |
| ViroPharma Incorporated | 0.6 | $755k | 25k | 30.20 | |
| Celsion Corporation | 0.5 | $680k | 125k | 5.44 | |
| Sunesis Pharmaceuticals | 0.5 | $671k | 119k | 5.63 | |
| Theravance | 0.5 | $648k | 25k | 25.92 | |
| Clovis Oncology | 0.4 | $461k | 23k | 20.45 | |
| Cornerstone Therapeutics | 0.3 | $358k | 69k | 5.15 | |
| PROLOR Biotech | 0.2 | $276k | 57k | 4.85 | |
| Elan Corporation | 0.2 | $268k | 25k | 10.72 |
